Use of ovatodiolide in the treatment or prevention of fibrotic conditions
AssigneeArjil Biotech Holding Company Limited
InventorsYeh B WU, Jir-Mehng LO, Hui-Ju LIANG, Pei-Hsin LIN, Kuo-Kuei HUANG
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of preventing or treating a fibrotic condition, comprising administering an effective amount of composition to a subject in need thereof; wherein the composition comprises triterpenes extracted from antrodia camphorate or Anisomeles indica.
Claims8
A method of preventing or treating a fibrotic condition in a subject, comprising administering to said subject a pharmaceutical composition comprising an effective amount of ovatodiolide or a metabolite thereof, wherein the fibrotic condition is selected from the group consisting of hepatic fibrosis, renal fibrosis, vascular fibrosis, pulmonary fibrosis and benign prostatic hyperplasia.
A method of treating renal dysfunction or renal injury in a subject, comprising administering to said subject a pharmaceutical composition comprising an effective amount of ovatodiolide or a metabolite thereof.
A method of alleviating non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), or an inflammation, vacuolation and necrosis in liver, comprising administering to said subject a pharmaceutical composition comprising an effective amount of ovatodiolide or a metabolite thereof.
Dependencies are inferred from the claim text.